News from the cochrane library: Maintenance of remission in ulcerative colitis;Neues aus der cochrane library: Remissionserhaltung bei colitis ulcerosa

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 5, 2007, Pages 395-396

  Timmer, Antje ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

COCHRANE LIBRARY; DRUG EFFICACY; DRUG INDICATION; HUMAN; REMISSION; SHORT SURVEY; TREATMENT OUTCOME; ULCERATIVE COLITIS; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; GERMANY; METHODOLOGY; PRACTICE GUIDELINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CLINICAL TRIALS; COLITIS, ULCERATIVE; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 34447273617     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963111     Document Type: Short Survey

References (10)

1. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta analysis of 5-aminoslicylic acid in the treatment of ulcerative colitis. Ann Int Med 1993; 118 (7): 540-549
2. Sutherland LR, Roth DE, Beck PL. Alternatives to sulfasalazine: a meta-analysis of 5-ASA in the treatment of ulcerative colitis. Inflamm Bowel Dis 1997; 3 (2): 65-78
3. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006; 2: CD000544
4. Timmer A, McDonald J, Macdonald J. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; 1: CD000478
5. Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107 (1): 3-11
6. Kruis W, Schreiber S. Colitis ulcerosa, Remissionserhaltung (Diagnostik und Therapie der Colitis ulcerosa: Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz chronisch entzündliche Darmerkrankungen. Z Gastroenterol 2004; 42 (9): 1011-1014
7. Kruis W, Schutz E, Fric P et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11 (5): 853-858
8. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40 (6): 775-781
9. Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 1995; 9 (3): 293-300
10. Marshall JK, Irvine EJ, Steinhart AH et al. Rectal corticosteroids for maintenance of remission in ulcerative colitis (Protocol). Cochrane Database Syst Rev 2003